These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34311790)

  • 61. Clinical features associated with ADB-BUTINACA exposure in patients attending emergency departments in England.
    King A; Hill SL; Pucci M; Bailey G; Keating L; Macfarlane R; Cantle F; Hudson S; Thomas SHL
    Clin Toxicol (Phila); 2022 Oct; 60(10):1094-1098. PubMed ID: 35943421
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Substance use, affective problems and personality traits: test of two association models].
    Chakroun N; Doron J; Swendsen J
    Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence for enduring cardiac and multiorgan toxicity after repeated exposure to the synthetic cannabinoid JWH-018 in male rats.
    Pintori N; Serra MP; Carai A; Lobina C; Isola R; Noli R; Piras G; Spano E; Baumann MH; Quartu M; De Luca MA
    Toxicology; 2024 Jul; 507():153878. PubMed ID: 38972446
    [TBL] [Abstract][Full Text] [Related]  

  • 64. What are the psychological effects of using synthetic cannabinoids? A systematic review.
    Akram H; Mokrysz C; Curran HV
    J Psychopharmacol; 2019 Mar; 33(3):271-283. PubMed ID: 30789300
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Photochemical Fingerprinting Is a Sensitive Probe for the Detection of Synthetic Cannabinoid Receptor Agonists; toward Robust Point-of-Care Detection.
    Andrews RC; May B; Hernández FJ; Cozier GE; Townsend PA; Sutcliffe OB; Haines TSF; Freeman TP; Scott J; Husbands SM; Blagbrough IS; Bowman RW; Lewis SE; Grayson MN; Crespo-Otero R; Carbery DR; Pudney CR
    Anal Chem; 2023 Jan; 95(2):703-713. PubMed ID: 36599091
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patterns of synthetic cannabinoid use in Australia.
    Barratt MJ; Cakic V; Lenton S
    Drug Alcohol Rev; 2013 Mar; 32(2):141-6. PubMed ID: 23043552
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L-valine or L-tert-leucine.
    Wouters E; Mogler L; Cannaert A; Auwärter V; Stove C
    Drug Test Anal; 2019 Aug; 11(8):1183-1191. PubMed ID: 31021521
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.
    Abouchedid R; Ho JH; Hudson S; Dines A; Archer JR; Wood DM; Dargan PI
    J Med Toxicol; 2016 Dec; 12(4):396-401. PubMed ID: 27456262
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.
    Werneck MA; Kortas GT; de Andrade AG; Castaldelli-Maia JM
    CNS Drugs; 2018 Dec; 32(12):1113-1129. PubMed ID: 30361897
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds.
    Wouters E; Walraed J; Robertson MJ; Meyrath M; Szpakowska M; Chevigné A; Skiniotis G; Stove C
    ACS Pharmacol Transl Sci; 2020 Apr; 3(2):285-295. PubMed ID: 32296768
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.
    Wouters E; Walraed J; Banister SD; Stove CP
    Biochem Pharmacol; 2019 Nov; 169():113623. PubMed ID: 31472128
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence].
    Chauchard E; Septfons A; Chabrol H
    Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues.
    Bonaccorso S; Metastasio A; Ricciardi A; Stewart N; Jamal L; Rujully NU; Theleritis C; Ferracuti S; Ducci G; Schifano F
    Brain Sci; 2018 Jul; 8(7):. PubMed ID: 30011896
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dedicated 'cannabis only' treatment clinics in New South Wales, Australia: client and treatment characteristics and associations with first-time treatment seeking.
    Copeland J; Allsop D
    Drug Alcohol Rev; 2014 Sep; 33(5):565-71. PubMed ID: 24902861
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs.
    Banister SD; Kevin RC; Martin L; Adams A; Macdonald C; Manning JJ; Boyd R; Cunningham M; Stevens MY; McGregor IS; Glass M; Connor M; Gerona RR
    Drug Test Anal; 2019 Jul; 11(7):976-989. PubMed ID: 30838752
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.
    Thornton LK; Baker AL; Johnson MP; Lewin T
    Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Self-esteem, coping, perceived social support and substance use in young adults with a cannabis dependence disorder].
    Dorard G; Bungener C; Corcos M; Berthoz S
    Encephale; 2014 Jun; 40(3):255-62. PubMed ID: 23928065
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample.
    Winstock A; Lynskey M; Borschmann R; Waldron J
    J Psychopharmacol; 2015 Jun; 29(6):698-703. PubMed ID: 25759401
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Semiquantitative Activity-Based Detection of JWH-018, a Synthetic Cannabinoid Receptor Agonist, in Oral Fluid after Vaping.
    Cannaert A; Ramírez Fernández MDM; Theunissen EL; Ramaekers JG; Wille SMR; Stove CP
    Anal Chem; 2020 Apr; 92(8):6065-6071. PubMed ID: 32200637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.